Treatment of Endometriosis with the GnRHa Deslorelin and Add-Back Estradiol and Supplementary Testosterone

Background. This randomized, multicenter, open-label clinical trial was intended to generate pilot data on the efficacy and safety of the gonadotropin-releasing hormone agonist (GnRHa) deslorelin (D) with low-dose estradiol ± testosterone (E(2)  ± T) add-back for endometriosis-related pelvic pain. M...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Biomed Res Int
Asıl Yazarlar: Agarwal, Sanjay K., Daniels, AnnaMarie, Drosman, Steven R., Udoff, Laurence, Foster, Warren G., Pike, Malcolm C., Spicer, Darcy V., Daniels, John R.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Hindawi Publishing Corporation 2015
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4736002/
https://ncbi.nlm.nih.gov/pubmed/26881208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/934164
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller